Do Allergy Shots Weaken Your Immune System? Myth vs. Science

No — allergy shots do not increase susceptibility to infections. Decades of AAAAI and ACAAI surveillance data covering tens of millions of injection visits have found no evidence of increased infection frequency or severity in allergy shot patients. This is consistent with the mechanism: SCIT modulates only allergen-specific immune pathways, leaving pathogen-defense systems — neutrophils, macrophages, NK cells, cytotoxic T cells, complement — structurally and functionally intact. In fact, by reducing chronic allergic inflammation that can impair mucosal barrier function, SCIT may indirectly reduce vulnerability to some respiratory infections.

No — allergy shots and immunosuppressants work through completely different mechanisms and have opposite effects on immune function. Immunosuppressants like prednisone, cyclosporine, and methotrexate broadly inhibit immune cell activation and proliferation, increasing infection risk, impairing wound healing, and carrying significant systemic side effects. SCIT targets only the allergen-specific Th2 pathway through Treg induction and IgG4 class-switch, with no broad immune suppression. A patient on prednisone has a genuinely weakened immune system; a patient receiving allergy shots has a specifically retrained immune system that is no less capable of fighting infection or disease than before treatment.

Allergy shots do not impair vaccine effectiveness. Multiple studies and the AAAAI/ACAAI Practice Parameter confirm that SCIT patients show normal antibody responses to vaccines including influenza, pneumococcal, and other standard immunizations. The immune compartments responsible for vaccine responses — B cells generating pathogen-specific antibodies, follicular helper T cells, and memory cells — are not targeted by SCIT's allergen-specific Treg induction. There is typically a practical recommendation to avoid scheduling allergy shots and vaccines on the same day to simplify reaction monitoring, but this is a logistical rather than an immunologic consideration.

No increase in autoimmune disease has been observed in allergy shot recipients across decades of clinical practice and pharmacovigilance. The AAAAI/ACAAI Practice Parameter notes that autoimmune conditions were traditionally listed as relative contraindications based on theoretical concern rather than documented cases. SCIT induces allergen-specific Tregs that suppress overactive Th2 responses — these regulatory T cells do not activate self-reactive immune pathways that drive autoimmunity. Multiple large population studies, including surveillance data covering tens of millions of injection visits, have not identified a signal for increased autoimmune disease in SCIT-treated populations.

The AAAAI/ACAAI Practice Parameter states that allergy shots are generally safe in immunocompetent patients with concurrent mild-to-moderate immunodeficiency, though significant immunodeficiency is listed as a relative contraindication. The theoretical concern is that severe immunodeficiency might impair the Treg-induction response required for tolerance, and could alter systemic reaction management if anaphylaxis occurs. Most allergists evaluate each patient individually — mild immune conditions such as selective IgA deficiency or well-controlled common variable immunodeficiency are assessed case by case. Patients with any immune condition should discuss with both their allergist and their treating physician before starting SCIT.

Fatigue or mild flu-like feelings after allergy shots are common and are the result of a temporary immune activation response, not immune suppression. When allergen extract is injected, the immune system mounts a localized inflammatory response — dendritic cells are activated, cytokines are released, and immune cells mobilize. This transient activation can feel similar to mild fatigue or malaise, much like how you might feel slightly tired after a flu vaccine. These symptoms typically resolve within 24 hours. They are a sign that the immune system is responding to the injection, not a sign that immunity is being weakened. Persistent or severe symptoms should be reported to your allergist.